Connect with us

Health

Nigeria to begin manufacturing vaccines soon

Published

on

Nigeria to begin manufacturing vaccines soon
Nigeria will start manufacturing vaccines soon adhering to required global standards.

“With regards to the establishment of the World Health Organization’s global benchmarking and adoption of international best practices, we want to get to maturity level three so that Nigeria can manufacture its vaccines,” The Nation reported, quoting Director-General of National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye.

“We are upgrading the agency’s laboratories to international standards using equipment that are compliant to ISO 17025. NAFDAC laboratories are changing very rapidly with improvements in new equipment and supplies,” she added.

Adeyeye noted that Nigeria aims to manufacture 70% of pharmaceuticals locally to cut down dependence on imports.

She said the NAFDAC is a leader in Africa “in terms of ensuring that the COVID-19 vaccines can be tracked and traced to the patients and also monitoring of adverse long reactions”.

” This is our new normal and it is because we are changing the way we think. After all, we want to safeguard the health of our people, “she said.

Besides Nigeria, India, and Thailand, are the other two countries focusing on local production of various vaccines, according to a US study released by the National Center for Biotechnology Information in 2019.

Despite that Africa represents 17% of the world’s population, and reportedly “has the highest incidence of mortality caused by infectious diseases,” it cannot remarkably manufacture vaccines that are considered essential to reduce mortality, and improving life expectancy, as well as promoting economic growth, said the study.

Facebook Comments
Copyright 2020 ROYAL NEWS. All rights reserved. Digital material on this website, may not be published, reproduced, broadcast, rewritten or redistributed in whole or in part without prior express written permission from ROYAL NEWS.

Contact: [email protected]

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending